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Abstract
Background: Gastrointestinal cancer surgery continues to be a significant cause of postoperative complications
and mortality in high-risk patients. It is crucial to identify these patients. Our study aimed to evaluate the accuracy
of specific perioperative risk assessment tools to predict postoperative complications, identifying the most
informative variables and combining them to test their prediction ability as a new score.
Methods: A prospective cohort study of digestive cancer surgical patients admitted to the surgical intermediate
care unit of the Portuguese Oncology Institute of Porto, Portugal was conducted during the period January 2016 to
April 2018. Demographic and medical information including sex, age, date from hospital admission, diagnosis,
emergency or elective admission, and type of surgery, were collected. We analyzed and compared a set of
measurements of surgical risk using the risk assessment instruments P-POSSUM Scoring, ACS NSQIP Surgical Risk
Calculator, and ARISCAT Risk Score according to the outcomes classified by the Clavien-Dindo score. According to
each risk score system, we studied the expected and observed post-operative complications. We performed a
multivariable regression model retaining only the significant variables of these tools (age, gender, physiological P-
Possum, and ACS NSQIP serious complication rate) and created a new score (MyIPOrisk-score). The predictive ability
of each continuous score and the final panel obtained was evaluated using ROC curves and estimating the area
under the curve (AUC).
Results: We studied 341 patients. Our results showed that the predictive accuracy and agreement of P-POSSUM
Scoring, ACS NSQIP Surgical Risk Calculator, and ARISCAT Risk Score were limited. The MyIPOrisk-score, shows to
have greater discrimination ability than the one obtained with the other risk tools when evaluated individually
(AUC = 0.808; 95% CI: 0.755–0.862). The expected and observed complication rates were similar to the new risk tool
as opposed to the other risk calculators.
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Conclusions: The feasibility and usefulness of the MyIPOrisk-score have been demonstrated for the evaluation of
patients undergoing digestive oncologic surgery. However, it requires further testing through a multicenter
prospective study to validate the predictive accuracy of the proposed risk score.
Keywords: Oncological digestive surgeries, Postoperative complications, Preoperative risk scoring, Prediction of
mortality
Introduction
Population-based cancer registries worldwide show an
increased incidence of gastrointestinal (GI) cancer (Fer-
lay et al., 2019; Global Burden of Disease Cancer Collab-
oration, 2017; González & Agudo, 2016). GI cancer
includes malignant neoplasms of the esophagus, gall-
bladder and biliary tract, liver, pancreas, stomach, small
intestine, bowel (large intestine or colon and rectum),
and anus. Treatment of these tumors mostly involves
surgery. Despite the improvements in anesthesia and
surgical techniques, GI cancer surgery (GICS) continues
to be a major cause of morbidity and mortality (Jhanji
et al., 2008; Weiser et al., 2008), contributing to postop-
erative complications (POC), which in high-risk patients,
may be associated with mortality of up to 80% (Mazo
et al., 2014; Fernandez-Bustamante et al., 2016). The
identification of high-risk patients in the preoperative
phase is of crucial importance as it will offer an oppor-
tunity to optimize the patient’s status with interventions
that contribute to recovery, such as prehabilitation
(West et al., 2017).
The American Society of Anesthesiologists Physical Status
classification system (ASA PS), P-Possum Score, American
College of Surgeons National Surgical Quality Improvement
Program (ACS NSQIP), and ARISCAT Risk predictor score
for postoperative pulmonary complications are some of the
most commonly used perioperative morbidity and mortality
risk prediction tools (Hackett et al., 2015; Miskovic & Lumb,
2017; Lubitz et al., 2017; Whiteley et al., 1996). The few pro-
spective studies comparing the accuracy of perioperative risk
scoring in GICS and their predictive capacity for mortality
and POC provide divergent results, pointing to some limita-
tions in predicting POC. These facts suggest that this area of
knowledge is still under-researched (Carvalho-e-Carvalho
et al., 2018). Moreover, the lack of consensus on how to de-
fine and grade postoperative adverse events has dramatically
hampered the evaluation of surgical procedures. To solve
this, Clavien-Dindo Classification revealed as an objective
and reproducible manner to rank POC complications (Dindo
& Clavien, 2004; Chereshneva et al., 2016). Using the classifi-
cation of surgical complications according to the Clavien-
Dindo score, as the outcome, we performed the analysis and
comparison of a set of measurements of surgical risk, namely
the P-POSSUM Scoring, ACS NSQIP Surgical Risk Calcula-
tor, and the ARISCAT Risk Score. The objective was to
evaluate their accuracy as perioperative risk assessment in-
struments in the prediction of postoperative morbidity in GI
cancer patients admitted in Surgical Intermediate Care Unit
(SICU). The most informative variables from each risk in-
strument were identified.
Materials and methods
Study design and patient population
A cohort study of GI cancer patients admitted to the
surgical intermediate care unit (SICU) of the Portuguese
Oncology Institute of Porto, Portugal (IPO-Porto) be-
tween January 2016 and April 2018 was conducted
retrospectively. Throughout this period, we included all
consecutive patients aged ≥ 18 years that underwent GI
cancer surgery and stayed in the SICU for ≥ 24 h. The
IPO-Porto Ethics Committee approved this study. The
ethical standards displayed in the 1964 Declaration of
Helsinki, and its later amendments were followed. Data
were made anonymous for analysis.
Demographic and medical information
Demographic and medical information including sex,
age, date of hospital admission, diagnosis, type of SICU
admission: ward-based postoperative complications or
elective surgery (elective), and type of surgery were col-
lected and retrospectively entered into an Excel spread-
sheet. We also classified patients according to the P-
Possum score (since the POSSUM model overestimates
the rate of complications in our sample; data not pub-
lished), ACS NSQIP (without surgeon adjustment of
risk), and ARISCAT Risk predictor. Scoring systems and
multivariable analysis from the collected data and med-
ical records according to defined criteria were done.
Additionally, we studied POC according to the Clavien-
Dindo classification.
Statistical analysis
Continuous variables were described by their median
and sample range (min–max). Categorical variables were
expressed as actual numbers (n) and percentages (%).
To evaluate the association between the occurrence of
major complications (Clavien-Dindo ≥ 3) and the poten-
tial explanatory variables, we performed a binary logistic
regression model. First, considering each variable separ-
ately and then making a multivariable model retaining
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only the significant variables (MyIPOrisk-score). The
predictive ability of each continuous score and the final
panel obtained was evaluated using receiving operating
characteristic (ROC) curves and estimating the area
under the curve (AUC). According to the ROC curve,
the cutoff was established in order to maximize the You-
den’s Index (sensitivity + specificity − 1). Also, the Hos-
mer–Lemeshow test was used to evaluate the fitted
models by comparing the number of predicted compli-
cations with the number of observed complications.
We performed a Venn diagram to enhance the rela-
tionship between different risk assessment tools in de-
tecting high-risk and low-risk patients as defined by the
cutoff value chosen using the criteria explained above.
Additionally, we compared the version used in the study
with the most recent version announced in the mean-
time to verify whether the variable serious complications
suffered significant changes.
Statistical significance was considered at the level of
P < 0.05. All statistical analysis was performed using the
software R v3.4.4.
Results
Description of the GI cancer patients admitted to the
SICU
The characteristics of the patients admitted at the SICU
are in Table 1. During the study period, a total of 341
patients (59.8% male) that underwent GI cancer surgery
(81.5% elective and 18.5% urgent), were admitted in the
SICU. Their ages ranged from 22 to 94, with a mean age
of 68 years, and approximately 60% of the patients had
an ASA score ≥ III.
The distribution of the performed surgeries was as fol-
lows: 103 (30.2%) colorectal surgeries, 60 (17.6%)
esophageal-gastric surgeries, 46 (13.5%) hepatic surgeries,
47 (13.8%) urgent laparotomies, 40 (11.7%) hyperthermic
intraperitoneal chemotherapy (HIPEC), 19 (5.6%) pancre-
atic surgeries, and 26 (7.6%) other surgeries.
One hundred and fifteen (33.7%) patients also per-
formed chemotherapy in the preoperative period.
Reasons for admission to the SICU were elective sur-
geries in patients with comorbidities (59, 17.3%), elective
complex surgeries (152, 44.6%), reoperations (63, 18.5%),
step-down care (47, 13.7%), and postoperative complica-
tions (20, 5.9%).
In the universe of 341 patients, the POC rate was
53.1% (181 patients), and its severity according to
Clavien-Dindo's classification was Grade I: 14 (7.7%) pa-
tients, Grade II: 82 (45.3%) patients, Grade IIIA: 24
(13.3%) patients, Grade IIIB: 25 (13.8%) patients, Grade
IVA: 10 (5.5%) patients, Grade IVB: 12 (6.6%) patients,
and Grade V: 14 (7.7%) patients. There were 55 deaths
with the following distribution: 12 deaths in the first 30
days (11 were surgical complication related), 10 deaths
between the 31st and 90th day (3 were surgical compli-
cation related), and 33 deaths after the 90th day.
Analysis post-operative complications by risk score
P-POSSUM predicted a more significant proportion of pa-
tients at high risk of morbidity (58.5% vs. 25.7%, respectively)
and mortality (12.8% vs. 9.7%, respectively) than the ACS
NSQIP Risk Calculator. Venn diagrams in Fig. 1 illustrates
the relationship between these two risk score tools in
Table 1 Characteristics of the 341 GI cancer patients admitted
at the SICU
Characteristics No. (%)


















Urgent laparotomies 47 (13.8)
Hyperthermic intraperitoneal chemotherapy (HIPEC) 40 (11.7)
Pancreatic 19 (5.6)
Other 26 (7.6)
Overall complications 181 (53.1)
Clavien-Dindo classification
Grade I 14 (7.7)
Grade II 82 (45.3)
Grade IIIA 24 (13.3)
Grade IIIB 25 (13.8)
Grade IVA 10 (5.5)
Grade IVB 12 (6.6)
Grade V 14 (7.7)
Mortality
30 D 12 (3.5)
90 D 22 (6.5)
F female, M male, D days
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detecting patients at high and low risk of developing compli-
cations. As shown, only 21.2% (n= 72) of patients were clas-
sified as high risk and 47.1% (n= 161) as low risk by both
tools. Comparing the version used in the study with the most
recent version in relation to the variable serious complica-
tions did not find significant changes.
Regarding pulmonary complications, ACS NSQIP Risk
Calculator predicted that 60.4% of patients could develop
pneumonia, and ARISCAT predicted that 67.5% of the pa-
tients were at risk of respiratory complications. The num-
ber of observed respiratory complications was 38 (11.1%),
of which 22 (6.4%) required intensive care support.
Comparison of the predicted and observed post-
operative complications
The Hosmer–Lemeshow goodness of fit test was used to
assess the calibration of the risk scores by comparing the
observed with anticipated complications by decile of risk
(Tables 2 and 3). P-POSSUM showed excellent perform-
ance, with an observed and expected complication ratio
ranging from 0.76 to 1.23 and an overall good fit (χ2 =
2.144; P = 0.976). On its turn, ACS NSQIP revealed dif-
ferent results. The number of observed complications
was less than expected by this tool in low deciles of risk,
while the number of expected complications was more
significant than the observed ones in higher deciles of
risk. Overall, it presented a significant lack of fit (χ2 =
18.540; P = 0.018).
Multivariable analysis of factors associated with major
postoperative complications
Table 4 shows the results of the univariable analysis for
major postoperative complications. The significant fac-
tors associated with the occurrence of major complica-
tions were gender (P < 0.001), surgery type (P < 0.001),
P-POSSUM physiological (P < 0.001) and surgical sever-
ity (P < 0.001), ACS NSQIP (P < 0.001), and ARISCAT
(P = 0.001).
Multivariable logistic regression (Table 5) revealed that
occurrence of major complications decreased signifi-
cantly with age (OR = 0.96; 95%CI: 0.93–0.98), was
higher in men (OR = 2.94; 95%CI: 1.52–5.71) and in-
creased with P-Possum (Physiological) score and ACS
NSQIP (serious complications) score (OR = 1.08; 95%CI:
1.03–1.12 and OR = 1.06; 95%CI: 1.03–1.09, respect-
ively). We used this model to predict probability of de-
veloping postoperative complications and named it as
MyIPOrisk-score. To dicotomize this score in low/high
risk, a cutoff was chosen using the Youden’s index. The
cutoff obtained was 23.5 being low risk attributed to pa-
tients with a score lower than this value. The equation
of predicted postoperative complication (MyIPOrisk-
score) was as follows:
Logit (Postoperative complications) = − 2.39 + (− 0.04) ×
Age + 1.08 if gender is male + 0.07 × P-POSSUM (Physio-
logical) + 0.06 × ACS NSQIP (Serious complications)
MyIPOrisk-score showed no significant lack of fit
(Table 6) (χ2 = 4.44; P = 0.815). The discriminatory ability
of the MyIPOrisk-score obtained with the final model
(AUC = 0.808; 95%CI: 0.755–0.862) was significantly
higher than the ability of each score individually (MyI-
POrisk-score vs. ACS NSQIP: P = 0.047; MyIPOrisk-score
vs. P-Possum: P = 0.028) (Fig. 2).
Discussion
In this study, we analyzed and compared the surgical
risk obtained by P-POSSUM Scoring, ACS NSQIP Surgi-
cal Risk Calculator, and ARISCAT Risk Score according
to the outcomes classified by the Clavien-Dindo score.
We aimed to evaluate their accuracy as perioperative
risk assessment instruments to predict postoperative
Fig. 1 Venn diagram showing the relationship between different risk
assessment tools in detecting high-risk and low-risk patients
Fernandes et al. Perioperative Medicine            (2020) 9:23 Page 4 of 9
morbidity and to identify the most informative variables.
Overall, our data suggest that (i) these instruments have
a poor predictive performance for POC; (ii) P-POSSUM
and ACS NSQIP Risk Calculator have poor agreement
for the identification of patients at high risk for morbid-
ity; and (iii) combining the most informative variables of
current risk models was superior in predicting POC than
each score individually.
The perioperative period is the perfect opportunity to
identify patients with increased risk profile for shared
and individualized decision-making and preoperative
optimization (e.g., prehabilitation) with the ultimate goal
of providing better outcomes (Hijazi et al., 2017). For
that purpose, several classical risk prediction models
(e.g., P-POSSUM Scoring, ACS NSQIP Surgical Risk
Calculator, and the ARISCAT Risk Score) were devel-
oped and prospectively validated and are currently used
worldwide (Huang et al., 2015; Lee et al., 2012; Copeland
et al., 1991; Haga et al., 1999; Miki et al., 2014; Kim
et al., 2008). However, a significant variation in terms of
the diagnostic accuracy of these models has been re-
ported in various surgical specialties, rising doubts about
their generalization (Kumagai et al., 2014; Yu et al.,
2016; SAH et al., n.d.). We observed a poor accuracy
and agreement (below 50%) between the studied models
in our cohort of GI cancer patients admitted to the
SICU, cautioning us to their routine use to assess pre-
operative risk for POC and support precision manage-
ment decisions.
To overcome this limitation, we performed this train-
ing set study and identified the most informative vari-
ables from current risk models assessed in our study,
with major complications (Clavien-Dindo ≥ 3) as the
outcome measure of reference. Binary logistic regression
identified that the occurrence of major complications
decreased significantly with age (OR = 0.96; 95%CI:











O:E (95% CI) X2HL
statistic
0–10 40 4 3.92 0.10 1.02 (0.27–2.61) 0.00
10–20 44 4 5.22 0.12 0.77 (0.21–1.96) 0.32
20–30 24 4 3.26 0.14 1.23 (0.33–3.14) 0.19
30–40 32 6 4.98 0.16 1.20 (0.44–2.62) 0.25
40–50 47 11 9.24 0.20 1.19 (0.59–2.13) 0.42
50–60 27 6 6.30 0.23 0.95 (0.35–2.07) 0.02
60–70 29 6 7.87 0.27 0.76 (0.28–1.66) 0.61
70–80 35 10 11.29 0.32 0.89 (0.42–1.63) 0.22
80–90 33 14 13.80 0.42 1.01 (0.55–1.70) 0.01
90–100 30 20 19.12 0.64 1.05 (0.64–1.62) 0.11
0–100 341 85 85 1.00 (0.80–1.22) 2.14
X2HL statistic = 2.144; df = 8; P = 0.976











O:E (95% CI) X2HL
statistic
0–10 34 1 2.12 0.06 0.47 (0.01–2.63) 0.63
10–20 35 2 3.00 0.09 0.67 (0.07–2.41) 0.37
20–30 33 2 3.62 0.11 0.55 (0.06–1.99) 0.82
30–40 34 8 4.98 0.15 1.61 (0.69–3.17) 2.15
40–50 36 3 6.29 0.17 0.48 (0.10–1.39) 2.09
50–60 32 10 6.71 0.21 1.49 (0.71–2.74) 2.04
60–70 34 15 8.72 0.26 1.72 (0.96–2.84) 6.08
70–80 35 10 11.13 0.32 0.90 (0.43–1.65) 0.17
80–90 33 9 14.69 0.45 0.61 (0.28–1.16) 3.98
90–100 34 25 23.73 0.70 1.05 (0.68–1.56) 0.22
0–100 340 85 85 1.00 (0.80–1.22) 18.54
X2HL statistic = 18.540; df = 8; P = 0.018
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0.93–0.98), was higher in men (OR = 2.94; 95%CI: 1.52–
5.71) and increased with P-Possum (Physiological) score
and serious complications ACS score (OR = 1.08; 95%CI:
1.03–1.12 and OR = 1.06; 95%CI: 1.03–1.09, respect-
ively). The decrease of risk with age is probably ex-
plained by the avoidance of complex surgical procedures
performed in older patients. When considered alone, the
ARISCAT score was also associated with the occurrence
of major complications but lost significance after adjust-
ing for the other variables. Our results are in agreement
with Scott S et al. (Scott et al., 2014), who found that the
Physiological score of POSSUM and P-POSSUM had
higher discrimination than the Operative score in pre-
dicting postoperative mortality at a critical care setting.
We did not find significant POC variation according to
age and gender, although there are references in the
literature about a relative preponderance in young pa-
tients undergoing surgery for GI cancer, probably due to
more extensive operations to which they are submitted.
As for gender discrimination, it seems to depend more
on the type of tumor involved (Alves et al., 2002; Knoferl
et al., 2002; Schroder et al., 1998).
Choi M et al., when testing the potential feasibility
of the ACS NSQIP Surgical Risk Calculator for pre-
dicting long-term cancer outcomes in patients with
resected pancreatic head cancer, found that the
serious complication rate parameter calculated with
this risk assessment instrument was the most inform-
ative (Choi et al., 2019).
Based on the informative variables of current risk
models, we constructed a model with a greater accuracy
to predict complications in the postoperative period in
GI cancer patients in need of surgery, that we named
MyIPOrisk-score. The discrimination ability of the MyI-
POrisk-score obtained with the final model (AUC =
0.808; 95%CI: 0.755–0.862) was significantly higher than
each score individually (MyIPOrisk-score vs ACS NSQIP:
P = 0.047; MyIPOrisk-score vs P-Possum: P = 0.028).
These results are very similar to those recently published
by Bihorac A et al. (Bihorac et al., 2019) that developed
and validated, in a cohort of 51,457 surgical patients
undergoing major inpatient surgery, an automated ana-
lytics framework for a preoperative risk algorithm to
forecast patient-level probabilistic risk scores for 8 major
postoperative complications (acute kidney injury, sepsis,
venous thromboembolism, intensive care unit admission
> 48 h, mechanical ventilation > 48 h, wound, neurologic,
and cardiovascular complications) and death up to 24
months after surgery. This model calculates probabilistic
risk scores for 8 postoperative complications with AUC
values ranging between 0.82 and 0.94 (99% confidence
intervals (CIs) 0.81–0.94). (Schroder et al., 1998) Import-
antly, the Hosmer–Lemeshow equation revealed that
MyIPOrisk-score presented the best association between
the number of observed complications and the number
of expected complications.
Our study is not free of limitations. It was a single-
center retrospective study, and some of the data were
collected from medical records, which could be a source
of bias due to the need of interpreting data. NSQIP may
change their model discrimination or calibration. How-
ever, our results did not present any quality change
when we used the latest versions of this score and com-
pared with the previous (the rate of serious complica-
tions is stable). Although MyIPOrisk-score needs other
scores to obtain a prediction, these are available for
everyone. The feasibility of the MyIPOrisk-score now re-
quires further testing through multicenter prospective
studies to validate the predictive accuracy of the pro-
posed risk score.
Table 4 Association between explanatory variables and major
postoperative complications (Clavien-Dindo ≥ 3)
Variable OR (95% CI) P value
Age 0.99 (0.97–1.01) 0.240
Gender
F 1
M 3.53 (1.97–6.34) < 0.001
Neoadjuvant chemotherapy
No 1
Yes 0.66 (0.38–1.14) 0.135
Surgery type
Elective 1
Reoperations 7.47 (4.12–13.53) < 0.001
ASA
2 1
3 1.67 (0.94–2.95) 0.080
4 21.27 (7.22–62.68) < 0.001
P-Possum
Physiological 1.11 (1.07–1.15) < 0.001
Surgical severity 1.20 (1.14–1.27) < 0.001
ACS NSQIP 1.09 (1.06–1.11) < 0.001
ARISCAT 1.03 (1.01–1.05) 0.001
F female, M male
Table 5 Significancy of variables involved in MyIPOriskScore
Variables OR 95% CI for OR
Lower Upper
Age 0.96 0.93 0.98
Gender (M/F) 2.94 1.52 5.71
PP (physiological) 1.08 1.03 1.12
ACS NSQIP (serious complication) 1.06 1.03 1.09
F female, M male
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The main interest in the use of this score is to identify
more accurately patients with high risk of having post-
operative complications so that they can be subjected to
a prehabilitation program in order to optimize their per-
formance in preoperative time and a postoperative care
in the SICU.
Conclusion
Based on the most informative variables of current risk
models, we developed a surgical risk score instrument that
showed greater performance in predicting risk of surgical
complications in GI cancer surgeries. However, it will be
necessary to evaluate its performance using a validation set.











O:E (95% CI) X2HL
statistic
0–10 34 2 1.15 0.03 1.75 (0.20–6.30) 0.66
10–20 34 0 2.07 0.06 0.00 (-) 2.20
20–30 34 3 3.06 0.09 0.98 (0.20–2.86) 0.00
30–40 34 4 4.01 0.12 1.00 (0.27–2.55) 0.00
40–50 34 7 5.25 0.15 1.33 (0.53–2.75) 0.69
50–60 34 8 6.34 0.19 1.26 (0.54–2.49) 0.53
60–70 34 7 8.40 0.25 0.83 (0.33–1.72) 0.31
70–80 34 11 10.91 0.32 1.01 (0.50–1.80) 0.00
80–90 34 16 16.42 0.48 0.97 (0.56–1.58) 0.02
90–100 34 27 27.39 0.81 0.99 (0.65–1.43) 0.03
0–100 340 85 85 1.00 (0.80–1.22) 4.44
X2HL statistic = 4.440; df = 8; P = 0.815
Fig. 2 ROC curve for the P-Possum, ACS NSQIP, ARISCAT, and MyIPOrisk-score scoring systems for predicting the rate of postoperative morbidity
(i.e., complications according to the Clavien-Dindo classification) in patients undergoing GICS. ROC receiver operating characteristic, AUC area
under the curve
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